Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Research Council grant · Running

BIO-MX Biomedical MXenes as cell labeling and tracking platforms

Coordinator
Universita Degli Studi Di Padova, Italy
Runs
1 January 2026 to 31 December 2030
Status
Running
EU funding
€2.5m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101199993

What the project is doing

In the project's own words, from its summary on CORDIS.

WHY Visualizing, labeling, and tracking cells is critical for advancements in biomedical research, especially in areas like cancer treatment and cell therapy. Over the past two decades, practices for cell labeling strategies have remained unchanged, facing the same critical technological limitation: a lack of versatility. By using a multidisciplinary approach to create MX-tags, a new class of nanomaterials, BIO-MX aims to overcome this limitation to accelerate biomedical discoveries and protect human health.

WHAT MX-tags will create an exciting chemical scenario coupled with single-cell mass cytometry (CyTOF), a revolutionary technology in cell biology. Although CyTOF has shaped the current understanding of cellular matter, fundamental needs remain to be addressed to enable new discoveries: 1. To develop universal cell tags that preserve cell functionality, are compatible with all cell types, and integrate seamlessly with advanced single-cell approaches.2.

To produce highly abundant chemically versatile tags able to multiplex the information on cells going beyond current limited available chemistries.3. To create sensitive and multi-function imaging tags to label, track, and provide spatial resolution of cells for cancer applications. HOW My ground-breaking idea is based on transforming the chemistry of 2D materials called MXenes to create MX-tags, a new class of multi-modular materials involving the peculiar properties of cell-penetrating peptides and nanobodies that will open new horizons for mass cytometry-based discoveries.

My unique expertise in CyTOF, immune cells, and 2D material development will drive the key steps of the project. My hypotheses rely on the future use of MX-tags as labeling, tracking, and multi-imaging tools. BIO-MX will provide transformative approaches and methods poised to contribute to human health.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di PadovaPadovaItalyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI